Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
biosimilar |
| gptkbp:activeIngredient |
gptkb:trastuzumab
|
| gptkbp:approvalYear |
2019
|
| gptkbp:ATCCode |
L01XC03
|
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
solution for infusion
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kanjinti
|
| gptkbp:indication |
gptkb:cancer
gastric cancer |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Amgen
|
| gptkbp:mechanismOfAction |
HER2 receptor antagonist
|
| gptkbp:product |
gptkb:Herceptin
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:bfsParent |
gptkb:trastuzumab
|
| gptkbp:bfsLayer |
7
|